Sekirov I - Search Results

1

In vitro efficacy of N-acetylcysteine on bacteria associated with chronic suppurative otitis media.

Lea J, Conlin AE, Sekirov I, Restelli V, Ayakar KG, Turnbull L, Doyle P, Noble M, Rennie R, Schreiber WE, Westerberg BD. Lea J, et al. Among authors: sekirov i. J Otolaryngol Head Neck Surg. 2014 Jul 7;43(1):20. doi: 10.1186/1916-0216-43-20. J Otolaryngol Head Neck Surg. 2014. PMID: 25001062 Free PMC article.

2

Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection.

Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, Finlay BB. Sekirov I, et al. Infect Immun. 2008 Oct;76(10):4726-36. doi: 10.1128/IAI.00319-08. Epub 2008 Aug 4. Infect Immun. 2008. PMID: 18678663 Free PMC article.

3

Neutrophil elastase alters the murine gut microbiota resulting in enhanced Salmonella colonization.

Gill N, Ferreira RB, Antunes LC, Willing BP, Sekirov I, Al-Zahrani F, Hartmann M, Finlay BB. Gill N, et al. Among authors: sekirov i. PLoS One. 2012;7(11):e49646. doi: 10.1371/journal.pone.0049646. Epub 2012 Nov 14. PLoS One. 2012. PMID: 23155475 Free PMC article.

4

Chronic thromboxane synthase inhibition prevents fructose-induced hypertension.

Galipeau D, Arikawa E, Sekirov I, McNeill JH. Galipeau D, et al. Among authors: sekirov i. Hypertension. 2001 Oct;38(4):872-6. Hypertension. 2001. PMID: 11641301

5

Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7.

Gruenheid S, Sekirov I, Thomas NA, Deng W, O'Donnell P, Goode D, Li Y, Frey EA, Brown NF, Metalnikov P, Pawson T, Ashman K, Finlay BB. Gruenheid S, et al. Among authors: sekirov i. Mol Microbiol. 2004 Mar;51(5):1233-49. doi: 10.1046/j.1365-2958.2003.03911.x. Mol Microbiol. 2004. PMID: 14982621 Free article.

6

Human and microbe: united we stand.

Sekirov I, Finlay BB. Sekirov I, et al. Nat Med. 2006 Jul;12(7):736-7. doi: 10.1038/nm0706-736. Nat Med. 2006. PMID: 16829917 No abstract available.

7

Type III secretion systems and disease.

Coburn B, Sekirov I, Finlay BB. Coburn B, et al. Among authors: sekirov i. Clin Microbiol Rev. 2007 Oct;20(4):535-49. doi: 10.1128/CMR.00013-07. Clin Microbiol Rev. 2007. PMID: 17934073 Free PMC article. Review.

8

Cross reactivity of enterohemorrhagic Escherichia coli O157:H7-specific sera with non-O157 serotypes.

Asper DJ, Sekirov I, Finlay BB, Rogan D, Potter AA. Asper DJ, et al. Among authors: sekirov i. Vaccine. 2007 Nov 28;25(49):8262-9. doi: 10.1016/j.vaccine.2007.09.054. Epub 2007 Oct 12. Vaccine. 2007. PMID: 17980466

9

Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.

Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. Lupp C, et al. Among authors: sekirov i. Cell Host Microbe. 2007 Aug 16;2(2):119-29. doi: 10.1016/j.chom.2007.06.010. Cell Host Microbe. 2007. PMID: 18005726 Free article.

10

Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.

Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. Lupp C, et al. Among authors: sekirov i. Cell Host Microbe. 2007 Sep 13;2(3):204. doi: 10.1016/j.chom.2007.08.002. Cell Host Microbe. 2007. PMID: 18030708 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters